Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreSofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.
Type de publicationJournal Article
Year of Publication2016
AuteursHoussel-Debry P, Coilly A, Fougerou-Leurent C, Jezequel C, Duvoux C, de Ledinghen V, Radenne S, Kamar N, Leroy V, Di Martino V, d'Alteroche L, Canva-Delcambre V, Conti F, Dumortier J, Montialoux H, Lebray P, Botta-Fridlund D, Anty R, Moreno C, Silvain C, Besch C, Perre P, Francoz C, Abergel A, Habersetzer F, Debette-Gratien M, Rohel A, Diallo A, Rossignol E, Danjou H, Veislinger A, Duclos-Vallee J-C, Pageaux G-P
JournalHEPATOLOGY
Volume64
Pagination465A
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0270-9139